Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Rd, Room 4315, Hyattsville, MD 20782, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 30.39). 02/2012; 307(5):491-7. DOI: 10.1001/jama.2012.39
Source: PubMed

ABSTRACT Between 1980 and 1999, the prevalence of adult obesity (body mass index [BMI] ≥30) increased in the United States and the distribution of BMI changed. More recent data suggested a slowing or leveling off of these trends.
To estimate the prevalence of adult obesity from the 2009-2010 National Health and Nutrition Examination Survey (NHANES) and compare adult obesity and the distribution of BMI with data from 1999-2008.
NHANES includes measured heights and weights for 5926 adult men and women from a nationally representative sample of the civilian noninstitutionalized US population in 2009-2010 and for 22,847 men and women in 1999-2008.
The prevalence of obesity and mean BMI.
In 2009-2010 the age-adjusted mean BMI was 28.7 (95% CI, 28.3-29.1) for men and also 28.7 (95% CI, 28.4-29.0) for women. Median BMI was 27.8 (interquartile range [IQR], 24.7-31.7) for men and 27.3 (IQR, 23.3-32.7) for women. The age-adjusted prevalence of obesity was 35.5% (95% CI, 31.9%-39.2%) among adult men and 35.8% (95% CI, 34.0%-37.7%) among adult women. Over the 12-year period from 1999 through 2010, obesity showed no significant increase among women overall (age- and race-adjusted annual change in odds ratio [AOR], 1.01; 95% CI, 1.00-1.03; P = .07), but increases were statistically significant for non-Hispanic black women (P = .04) and Mexican American women (P = .046). For men, there was a significant linear trend (AOR, 1.04; 95% CI, 1.02-1.06; P < .001) over the 12-year period. For both men and women, the most recent 2 years (2009-2010) did not differ significantly (P = .08 for men and P = .24 for women) from the previous 6 years (2003-2008). Trends in BMI were similar to obesity trends.
In 2009-2010, the prevalence of obesity was 35.5% among adult men and 35.8% among adult women, with no significant change compared with 2003-2008.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction. The association between incarceration and weight gain, along with the public health impact of former prisoners who are overweight or obese, warrants more investigation to understand the impact of prison life. Studies regarding incarceration's impact on obesity are too few to support assertions that prisons contribute to obesity and comorbid conditions. This study examined a statewide prison population over several years to determine weight gain. Methods. Objective data for weight, height, and chronic diseases, along with demographics, were extracted from an electronic health record. These data were analyzed statistically to determine changes over time and between groups. Results. As a total population, prisoners not only gained weight, but also reflected the distribution of BMIs for the state. There were differences within the population. Male prisoners gained significantly less weight than females. The population with chronic diseases gained less weight than the population without comorbid conditions. Prisoners with diabetes lost weight while hypertension's impact was negligible. Conclusion. This study found that weight gain was a problem specifically to females. However, this prison system appears to be providing effective chronic disease management, particularly for prisoners with diabetes and hypertension. Additional research is needed to understand the impact incarceration has on the female population.
    Journal of obesity 01/2015; 2015:532468. DOI:10.1155/2015/532468
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nonalcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide affecting over one-third of the population in the U.S. It has been associated with obesity, type 2 diabetes, hyperlipidemia, and insulin resistance and is initiated by the accumulation of triglycerides in hepatocytes. Isolated hepatic steatosis (IHS) remains a benign process, while a subset develops superimposed inflammatory activity and progression to nonalcoholic steatohepatitis (NASH) with or without fibrosis. However, the molecular mechanisms underlying NAFLD progression are not completely understood. Liver biopsy is still required to differentiate IHS from NASH as easily accessible noninvasive biomarkers are lacking. In terms of treatments for NASH, pioglitazone, vitamin E, and obeticholic acid have shown some benefit. All of these agents have potential complications associated with long-term use. Nowadays, a complex hypothesis suggests that multiple parallel hits are involved in NASH development. However, the 'key switch' between IHS and NASH remains to be discovered. We have recently shown that knocking out enzymes involved in S-adenosylmethionine (SAMe) metabolism, the main biological methyl donor in humans that is abundant in the liver, will lead to NASH development in mice. This could be due to the fact that a normal SAMe level is required to establish the proper ratio of phosphatidylethanolamine to phosphatidylcholine that has been found to be important in NAFLD progression. New data from humans have also suggested that these enzymes play a role in the pathogenesis of NAFLD and that some of SAMe cycle metabolites may serve as noninvasive biomarkers of NASH. In this review, we discuss the evidence of the role of SAMe in animal models and humans with NAFLD and how studying this area may lead to the discovery of new noninvasive biomarkers and possibly personalized treatment for NASH. © 2015 by the Society for Experimental Biology and Medicine.
    Experimental Biology and Medicine 04/2015; DOI:10.1177/1535370215579161 · 2.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to examine differences in total daily energy expenditure (TDEE), energy expenditure in various intensities, as well as total daily energy intake (TDEI) and diet quality in normal weight, overweight and obese men and women. Further, the association of energy expenditure and energy intake with body fatness was examined. The cross-sectional analysis included 430 adults (27.7±3.8 years; 49.3% male). Body weight and height were measured according to standard procedures and percent body fat (BF) was assessed via dual X-ray absorptiometry. Energy expenditure was determined via the SenseWear Armband. Energy intake and the Healthy Eating Index (HEI) were calculated based on multiple 24-h recalls. Weight adjusted TDEI and TDEE were significantly lower in overweight and obese adults compared to their normal weight peers (p<0.001) and obese women had a lower HEI (p=0.006). Overweight and obese adults further displayed a higher proportion of energy expenditure spent in sedentary and in light activities (p<0.001), while the proportion of energy expenditure in moderate-to-vigorous physical activity (MVPA) was lower compared to their normal weight peers (p<0.001). The inverse relationship between BMI or BF and MVPA was stronger than the positive association between BMI or BF and the proportion of energy expended in sedentary or light pursuits (rMPA=-0.45 to -0.67/rMVPA=-0.51 to -0.66 vs. rSedentary=0.33 to 0.52/rlight=0.36 to 0.47; p<0.001). These findings emphasise the importance of MPA and bouts of MVPA regarding the maintenance of a normal body weight. Copyright © 2015 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.
    Obesity Research & Clinical Practice 04/2015; DOI:10.1016/j.orcp.2015.03.007 · 0.70 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014